Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore effective wealth management for families to enhance your collective financial health and achieve shared financial goals.
19,633 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A prominent market analyst says Ethereum may be near a bottom, even as Vitalik Buterin sells ETH. Traders are weighin...
A Nevada mom pulled off an audacious scam, selling fake creator trips and later faking cancer to cover it up. This ca...
RE/MAX brokers are turning to repeatable systems over lofty goals to push growth amid market shifts, with panels at R...
In a volatile market, CVS Health leads a retirement-focused view of the magic formula, topping Qualcomm and Valero as...
Natural gas prices push higher, renewing interest in AMLP. Retirees weigh the fund’s 7.6% yield and rising distributi...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
Salesforce unveiled a $50 billion buyback and a new AI metric, but traders remain wary that AI disruption could erode...
Taylor Morrison’s proxy shows a patient, staged sale to Berkshire Hathaway, highlighting a cautious appetite for big-...
Netflix stock climbed today as investors weighed growth momentum and the potential move of a major deal. This article...
A simple on-screen warning can open a doorway to financial ruin. This article unpacks a real-world fake Microsoft ale...
Ethereum rebounds from a mid-$1,700s slip, but the rebound sits at a critical crossroad. The question: is this a reli...